REFERENCES
- Barnes P M, Bloom B, Nahin R. CDC National Health Statistics Report #12. Complementary and alternative medicine use among adults and children: United States. 2007, December 10, 2008
- Etheridge A S, Black S R, Patel P R, So J, Mathews J M. An in vitro evaluation of cytochrome p450 inhibition and p-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med. 2007; 73(8)731–741
- Gaudineau C, Beckerman R, Welbourn S, Auclair K. Inhibition of human p450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem Biophys Res Commun. 2004; 318(4)1072–1078
- Graefe E U, Wittig J, Mueller S, Riethling A K, Uehleke B, Drewelow B, et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol. 2001; 41(5)492–499
- Harris J W, Rahman A, Kim B R, Guengerich F P, Collins J M. Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res 1994; 54: 4026–4035
- Hensley M L, Correa D D, Thaler H, Wilton A, Venkatraman E, Sabbatini P, Chi D S, Dupont J, Spriggs D, Aghajanian C. Phase i/ii study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecol Oncol. 2006; 17: 17
- Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients—evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer. 2005; 12(4)279–287
- Oliveira E J, Watson D G, Grant M H. Metabolism of quercetin and kaempferol by rat hepatocytes and the identification of flavonoid glycosides in human plasma. Xenobiotica. 2002; 32(4)279–287
- Rahman A, Korzekwa K R, Grogan J, Gonzalez F J, Harris J W. Selective biotransformation of taxol to 6α -hydroxytaxol by human cytochrome P450 2C8. Cancer Res 1994; 54: 5543–5546
- Si D, Wang Y, Guo Y, Wang J, Zhou H, Zhou Y H, Li Z S, Fawcett J P. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab Dispos. 2008, [Epub ahead of print]
- Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med. 2004; 36(7)829–837
- Zaks-Zilberman M, Zaks T Z, Vogel S N. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (taxol) in murine and human breast cancer cell lines. Cytokine. 2001; 15(3)156–165